Retrospective analysis of sorafenib combined with interferon α-1b, interleukin-2, and thalidomide as maintenance therapy in FLT3-ITD-positive acute myeloid leukemia
The sorafenib combined with ITI regimen is an effective maintenance therapy for FLT3-ITD (+) AML, significantly reducing relapse risk and prolonging survival.
Authors
- Dongbei Li
- Cheng Cheng (ORCID: https://orcid.org/0000-0002-2497-1712)
- Lin Chen (ORCID: https://orcid.org/0000-0002-1108-4735)
- Xudong Wei (ORCID: https://orcid.org/0000-0002-3325-0837)
- Ruihua Mi
Institutions
- Henan Academy of Sciences (CN)
- Henan Cancer Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-12
- DOI
- https://doi.org/10.3389/fonc.2025.1698935
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province